Publication Scientifique (anglais):
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Accueil > Ressources > Publication Scientifique (anglais):
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Retourner à la liste

May 15, 2019

Powles T et al. Nature Medicine 2019;25:1706–1714.

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Accédez à la publication